DALLAS, TX / ACCESS Newswire / January 24, 2025 / DZS (OTC PINK:DZSI), a developer of Network Edge and Connectivity systems and Cloud Edge software solutions enabling broadband everywhere, today announced that Geoff Burke, Senior Vice President of Marketing and Investor Relations, will participate and present at the Dealflow Events MicroCap Conference 2025. The conference is being held January 28-30, 2025, at the Borgata Hotel Casino & Spa in Atlantic City, N.J.
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DZS Inc. (OTC: DZSI) on behalf of long-term stockholders following a class action complaint that was filed against DZS on June 14, 2023 with a Class Period from March 10, 2023 to May 31, 2023. Our investigation concerns whether the board of directors of DZS have breached their fiduciary duties to the company.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500, also rose, gaining, 0.01% to 4,462.11.
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500, also rose, gaining, 0.30% to 4,475.23.
